PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9486655-4 1998 However, treatment with RA induces differentiation of leukaemic blast cells and disease remission in PML-RARalpha APLs, whereas PLZF-RARa APLs are resistant to RA. Tretinoin 24-26 PML nuclear body scaffold Homo sapiens 101-104 9486655-4 1998 However, treatment with RA induces differentiation of leukaemic blast cells and disease remission in PML-RARalpha APLs, whereas PLZF-RARa APLs are resistant to RA. Tretinoin 24-26 retinoic acid receptor alpha Homo sapiens 105-113 9486655-4 1998 However, treatment with RA induces differentiation of leukaemic blast cells and disease remission in PML-RARalpha APLs, whereas PLZF-RARa APLs are resistant to RA. Tretinoin 24-26 retinoic acid receptor alpha Homo sapiens 105-109 9486655-4 1998 However, treatment with RA induces differentiation of leukaemic blast cells and disease remission in PML-RARalpha APLs, whereas PLZF-RARa APLs are resistant to RA. Tretinoin 105-107 PML nuclear body scaffold Homo sapiens 101-104 9486655-7 1998 PLZF-RARalpha contains a second, RA-resistant binding site in the PLZF amino-terminal region. Tretinoin 5-7 zinc finger and BTB domain containing 16 Homo sapiens 0-4 9486655-7 1998 PLZF-RARalpha contains a second, RA-resistant binding site in the PLZF amino-terminal region. Tretinoin 5-7 zinc finger and BTB domain containing 16 Homo sapiens 66-70 9486655-8 1998 High doses of RA release histone deacetylase activity from PML-RARalpha, but not from PLZF-RARalpha. Tretinoin 14-16 PML nuclear body scaffold Homo sapiens 59-62 9486655-8 1998 High doses of RA release histone deacetylase activity from PML-RARalpha, but not from PLZF-RARalpha. Tretinoin 14-16 retinoic acid receptor alpha Homo sapiens 63-71 9486655-10 1998 Therefore, recruitment of histone deacetylase is crucial to the transforming potential of APL fusion proteins, and the different effects of RA on the stability of the PML-RARalpha and PLZF-RARalpha co-repressor complexes determines the differential response of APLs to RA. Tretinoin 140-142 PML nuclear body scaffold Homo sapiens 167-170 9486655-10 1998 Therefore, recruitment of histone deacetylase is crucial to the transforming potential of APL fusion proteins, and the different effects of RA on the stability of the PML-RARalpha and PLZF-RARalpha co-repressor complexes determines the differential response of APLs to RA. Tretinoin 140-142 retinoic acid receptor alpha Homo sapiens 171-179 9486655-10 1998 Therefore, recruitment of histone deacetylase is crucial to the transforming potential of APL fusion proteins, and the different effects of RA on the stability of the PML-RARalpha and PLZF-RARalpha co-repressor complexes determines the differential response of APLs to RA. Tretinoin 140-142 zinc finger and BTB domain containing 16 Homo sapiens 184-188 9486655-10 1998 Therefore, recruitment of histone deacetylase is crucial to the transforming potential of APL fusion proteins, and the different effects of RA on the stability of the PML-RARalpha and PLZF-RARalpha co-repressor complexes determines the differential response of APLs to RA. Tretinoin 140-142 retinoic acid receptor alpha Homo sapiens 189-197 9486655-10 1998 Therefore, recruitment of histone deacetylase is crucial to the transforming potential of APL fusion proteins, and the different effects of RA on the stability of the PML-RARalpha and PLZF-RARalpha co-repressor complexes determines the differential response of APLs to RA. Tretinoin 171-173 PML nuclear body scaffold Homo sapiens 167-170